If you use respiratory treatments at home, understanding how to make saline solution for nebulizer use can be helpful in ...

A 2026 informational consumer research report examining portable nebulizer technology, vibrating mesh atomization systems, respiratory comfort features, pricing transparency, and verification ...

After NFL quarterback Boomer Esiason's son was diagnosed with cystic fibrosis, it put a face on a little-known disease and ...

Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...

Despite struggling with severe asthma and suffering a broken spine in an accident, Kelsey O'Driscoll is now set to compete at ...

Vitality Medical reports that a state analysis shows respiratory care demand varies widely, with the South having high burden ...

Achieved YUTREPIA® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth ...

An updated December 2025 ERS clinical practice guideline provides evidence-based recommendations for managing adult ...

Achieved YUTREPIA net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarterMore than 3,600 unique prescriptions received and 2,900 patients treated to date si ...

Savara Inc. (the "Company") , a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 Letter from the FDA which indicated that ...